In May 2026, Amylyx Pharmaceuticals announced that the topline results from the Phase III (LUCIDITY) evaluating avexitide in PBH are anticipated in Q3 2026, and if approved, the commercial launch is anticipated in 2027
If the information does not match their records, there may be delays in processing your prior authorization
Pascuzzi RM
In high-fat diet-induced obese mice, the abundance of Blautia producta in the gut flora increases, leading to elevated 2-OG levels
I offer a free 30-minute consultation to support your sleep, hormones, or next right step on your healing path
Scientists have conducted over 100 studies examining its effects on various tissues including tendons, ligaments, muscles, the gastrointestinal tract, and the nervous system